reference/7235696

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/7235696

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, Non-U.S. Gov't
endingPage	4594
issn	1527-7755 0732-183X
issueIdentifier	28
pageRange	4587-4594
publicationName	Journal of clinical oncology : official journal of the American Society of Clinical Oncology
startingPage	4587
bibliographicCitation	Fu K, Weisenburger DD, Choi WW, Perry KD, Smith LM, Shi X, Hans CP, Greiner TC, Bierman PJ, Bociek RG, Armitage JO, Chan WC, Vose JM. Addition of rituximab to standard chemotherapy improves the survival of both the germinal center B-cell-like and non-germinal center B-cell-like subtypes of diffuse large B-cell lymphoma. J Clin Oncol. 2008 Oct 01;26(28):4587–94. doi: 10.1200/jco.2007.15.9277. PMID: 18662967.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ed88bcfa257fc81870a80096e27d7e55 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6ca67dd6d7404f9707aec93c81d281db http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f434f2bcc51a0b0875f41d2a72a7745a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_48c663552a15a1ec3f33f40c755b2605 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e037f00de4f2b7b1a96d199f65f76793 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_914ad1c5aaf28e0d9d0ea080546c14f8 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_29a69643bc434a8a0bddcf02cca98881 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_525deaca6e55335a6215b6ad0097cf77 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c11b1b83ca287cbf15c977ba3af1f398 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_404fab54d711d50a4a2c38c9c0e92e74 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_96ec5447e685e97598d369bcd4143e68 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b47e94838d17198b965727135d217c62 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9fa7f16825d73cf2f41375cffaa7c132
date	2008-10-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1200/jco.2007.15.9277 https://pubmed.ncbi.nlm.nih.gov/18662967
isPartOf	https://portal.issn.org/resource/ISSN/0732-183X http://rdf.ncbi.nlm.nih.gov/pubchem/journal/5023 https://portal.issn.org/resource/ISSN/1527-7755
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Addition of Rituximab to Standard Chemotherapy Improves the Survival of Both the Germinal Center B-Cell–Like and Non–Germinal Center B-Cell–Like Subtypes of Diffuse Large B-Cell Lymphoma
discusses	http://id.nlm.nih.gov/mesh/M0544940 http://id.nlm.nih.gov/mesh/M0005485 http://id.nlm.nih.gov/mesh/M0013954 http://id.nlm.nih.gov/mesh/M0017460 http://id.nlm.nih.gov/mesh/M0017465 http://id.nlm.nih.gov/mesh/M0022676 http://id.nlm.nih.gov/mesh/M0006784 http://id.nlm.nih.gov/mesh/M0244307 http://id.nlm.nih.gov/mesh/M0001357
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D000971Q000627 http://id.nlm.nih.gov/mesh/D016403Q000188 http://id.nlm.nih.gov/mesh/D000911Q000008
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D000971Q000008 http://id.nlm.nih.gov/mesh/D058846 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D014750Q000008 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D016016 http://id.nlm.nih.gov/mesh/D016403Q000473 http://id.nlm.nih.gov/mesh/D011239Q000008 http://id.nlm.nih.gov/mesh/D016896 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D015996 http://id.nlm.nih.gov/mesh/D011379 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D016009 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D018858Q000473 http://id.nlm.nih.gov/mesh/D008942Q000008 http://id.nlm.nih.gov/mesh/D003520Q000008 http://id.nlm.nih.gov/mesh/D018450 http://id.nlm.nih.gov/mesh/D004317Q000008 http://id.nlm.nih.gov/mesh/D011241Q000008 http://id.nlm.nih.gov/mesh/D000369 http://id.nlm.nih.gov/mesh/D000069283 http://id.nlm.nih.gov/mesh/D000368

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129717275 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128812924 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128397534

Total number of triples: 71.